Trial Profile
Interaction potential between emtricitabine/tenofovir-alafenamide (F/TAF) and cobicistat/darunavir
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Sep 2015
Price :
$35
*
At a glance
- Drugs Cobicistat/darunavir (Primary) ; Emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Gilead Sciences
- 14 Sep 2015 New trial record